22
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The aryl hydrocarbon receptor (AhR) is an evolutionarily old transcription factor belonging to the Per-ARNT-Sim-basic helix-loop-helix protein family. AhR translocates into the nucleus upon binding of various small molecules into the pocket of its single-ligand binding domain. AhR binding to both xenobiotic and endogenous ligands results in highly cell-specific transcriptome changes and in changes in cellular functions. We discuss here the role of AhR for immune cells of the barrier organs: skin, gut, and lung. Both adaptive and innate immune cells require AhR signaling at critical checkpoints. We also discuss the current two prevailing views-namely, 1) AhR as a promiscuous sensor for small chemicals and 2) a role for AhR as a balancing factor for cell differentiation and function, which is controlled by levels of endogenous high-affinity ligands. AhR signaling is considered a promising drug and preventive target, particularly for cancer, inflammatory, and autoimmune diseases. Therefore, understanding its biology is of great importance.

          Related collections

          Author and article information

          Journal
          Pharmacol Rev
          Pharmacological reviews
          American Society for Pharmacology & Experimental Therapeutics (ASPET)
          1521-0081
          0031-6997
          2015
          : 67
          : 2
          Affiliations
          [1 ] Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (C.E.); and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (A.R.) chesser@uni-duesseldorf.de.
          [2 ] Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (C.E.); and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (A.R.).
          Article
          67/2/259
          10.1124/pr.114.009001
          25657351
          4e19bb88-3d09-41a3-8bdc-41e8d2574495
          Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.
          History

          Comments

          Comment on this article